Toxocara and Toxocariasis

Dr. Bowman is a Professor in the Department of Microbiology and Immunology, Cornell University, NY, and has been associated with the department since 1987 (previously an assistant professor,1987-1993). He received the MS degree in Parasitology from Tulane University in 1976. He then received his PhD from Tulane University in 1983 studying Parasitology. He has held successive positions at Cornell University since 1987. He has obtained continuous funding (corporate and federal) throughout his career to study animal parasitology.

• PART I - The organism and the recognition of the disease1. Toxocara: Protecting pets and improving the lives of people2. History of Toxocara and the associated larva migrans3. The anatomy of the third-stage larva of Toxocara canis and Toxocara cati4. Visceral larval migrans of Toxocara canis and Toxocara cati in non-canid and non-felid hosts5. Toxocara “omics” and the promises it holds for medicine and veterinary medicinePART II - The effects of infection, host response to infection, diagnosis, and treatment of people6. Toxocariasis and the clinical spectrum7. Serodiagnostic methods for diagnosing larval toxocariasis8. Clinical pathology of larval toxocariasis9. Imaging of toxocariasis10. Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts11. Neurotoxocariasis12. Pathogenesis of cerebral toxocariasis and neurodegenerative diseases13. Neurocognitive and neuropsychiatric effects of toxocariasisPART III – Epidemiology14. Global and regional seroprevalence estimates for human toxocariasis: A call for action15. Toxocara seroprevalence in Canada—Climate, environment and culture16. Toxocara seroprevalence in the USA and its impact for individuals and society17. Toxocara: Seroprevalence in Mexico18. Seroprevalence Brazil19. Seroprevalence of human toxocarosis in Europe: A review and meta-analysis20. Seroprevalence and incidence of human toxocarosis in Russia21. Current epidemic situation of human toxocariasis in China22. Seroprevalence of Toxocara spp. infection in Southeast Asia and Taiwan23. Sources and seroprevalence of toxocariasis in Turkey24. Seroprevalence of Toxocara spp. antibodies in humans in Africa: A review25. Seroepidemiology of human toxocariasis in North AfricaPART IV - Dogs (and cats) disease, diagnosis, prevalence of infection, and treatment26. Pathology of larvae and adults in dogs and cats27. Antigen detection: Insights into Toxocara and other ascarid infections in dogs and cats28. Global prevalence of Toxocara infection in dogs29. Sources of environmental contamination with Toxocara spp.: An omnipresent parasite30. Global prevalence of Toxocara infection in cats31. Toxocara spp. in dogs and cats in Canada32. Toxocara canis and Toxocara cati in domestic dogs and cats in the United States, Mexico, Central America and the Caribbean: A review33. Toxocara prevalence in dogs and cats in Brazil34. Prevalence of Toxocara spp. in dogs and cats in South America (excluding Brazil)35. Prevalence of patent Toxocara spp. infections in dogs and cats in Europe from 1994 to 201936. Toxocara prevalence in dogs, cats and the environment in Russia37. Canine Toxocariosis: Its prevalence, incidence and occurrence in the Indian subcontinent38. Epidemiology of Toxocara spp. in dogs and cats in mainland China, 2000–201939. Prevalence of Toxocara in dogs and cats in Africa40. Toxocara canis in Australia41. Toxocariasis: A neglected infection for the Anthropocene epoch